Publication | Open Access
Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo
49
Citations
22
References
2019
Year
This study provides a rationale for combining oHSV with trametinib for the treatment of brain tumors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1